US2004265881A1PendingUtilityA1
Ace genotype which correlates with improved success in sodium excretion in hypertensives with exercise
Est. expiryNov 13, 2020(expired)· nominal 20-yr term from priority
C12Q 1/6883C12Q 2600/156
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of increasing sodium excretion levels in a hypertensive subject by identifying a subject having an II genotype for an angiotensin converting enzyme gene, and engaging the subject in limited exercise training for a period of time sufficient to increase the subject's sodium excretion levels.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method of increasing sodium excretion levels in a hypertensive subject, the method comprising:
identifying a hypertensive subject having an II genotype for an angiotensin converting enzyme gene, wherein the subject is in need of increased sodium excretion levels; and engaging the subject in limited exercise training for a period of time sufficient to increase sodium excretion levels in the subject.Join the waitlist — get patent alerts
Track US2004265881A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.